CA956573A - Preparation of a pathological process inhibitor and applications - Google Patents

Preparation of a pathological process inhibitor and applications

Info

Publication number
CA956573A
CA956573A CA101,323A CA101323A CA956573A CA 956573 A CA956573 A CA 956573A CA 101323 A CA101323 A CA 101323A CA 956573 A CA956573 A CA 956573A
Authority
CA
Canada
Prior art keywords
applications
preparation
pathological process
process inhibitor
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA101,323A
Other languages
English (en)
Other versions
CA101323S (en
Inventor
Georges Mathe
Jean-Claude Chermann
Marcel Raynaud
Claude Jasmin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Application granted granted Critical
Publication of CA956573A publication Critical patent/CA956573A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA101,323A 1969-12-31 1970-12-22 Preparation of a pathological process inhibitor and applications Expired CA956573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6945776A FR2073293B1 (fr) 1969-12-31 1969-12-31

Publications (1)

Publication Number Publication Date
CA956573A true CA956573A (en) 1974-10-22

Family

ID=9045518

Family Applications (1)

Application Number Title Priority Date Filing Date
CA101,323A Expired CA956573A (en) 1969-12-31 1970-12-22 Preparation of a pathological process inhibitor and applications

Country Status (11)

Country Link
JP (1) JPS4940922B1 (fr)
AT (1) AT301749B (fr)
BE (1) BE760727A (fr)
CA (1) CA956573A (fr)
CH (1) CH533988A (fr)
DE (1) DE2064296C2 (fr)
DK (1) DK128054B (fr)
FR (1) FR2073293B1 (fr)
GB (1) GB1326928A (fr)
LU (1) LU62332A1 (fr)
NL (1) NL7019097A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5330639U (fr) * 1976-08-20 1978-03-16
CH664494A5 (it) * 1979-10-11 1988-03-15 Liborio Dott Bonifacio Procedimento per preparare antidoti per la prevenzione e la cura dei tumori, dagli escrementi delle capre.
JPS5925332A (ja) * 1982-08-04 1984-02-09 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製法
FR2568125B1 (fr) * 1984-07-25 1988-04-15 Kogo Michiko Agent anti-tumeur contenant la proteine du sucre
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment

Also Published As

Publication number Publication date
DE2064296A1 (de) 1971-07-15
DK128054B (da) 1974-02-25
CH533988A (fr) 1973-02-28
FR2073293B1 (fr) 1973-01-12
AT301749B (de) 1972-09-11
FR2073293A1 (fr) 1971-10-01
NL7019097A (fr) 1971-07-02
DE2064296C2 (de) 1984-10-25
JPS4940922B1 (fr) 1974-11-06
LU62332A1 (fr) 1971-05-27
BE760727A (fr) 1971-05-27
GB1326928A (en) 1973-08-15

Similar Documents

Publication Publication Date Title
CA918160A (en) Butyrophenonederivatives and methods of their production
CA956573A (en) Preparation of a pathological process inhibitor and applications
CA924196A (en) Application of precipitates of methylene-ureas and products obtained
AU1986970A (en) 3-acyl-8-resorcylic anilides and process for their manufacture
CA919169A (en) 6 .alpha.-METHYL-19-NOR-PROGESTERONE AND A PROCESS OF ITS MANUFACTURE
CA926861A (en) Manufacture of lysergols
CA930327A (en) Manufacture of cyclohexadiene-dioic acids
CA828150A (en) Photopolymers and the process of making same
CA814937A (en) Photopolymerizable element and process of preparation
AU436394B2 (en) Manufacture of bipyridlylium and related compounds
CA810678A (en) Manufacture of sulpholenes and sulpholanes
CA812156A (en) Manufacture of interhalogen compounds and halogenoids
CA816134A (en) Modification of 2:6-dibenzoylamino-3:7-diethoxy-9:10-diacetylamino-triphendioxazine and processes for its manufacture
CA798368A (en) Trifluoroethoxyethyl acrylate and its process of manufacture
AU1218870A (en) Process forthe manufacture of cyclobutanones
AU1505270A (en) Production of trimethyl-2-cyclohexen-1-ones
CA804005A (en) Nitrogen-sulphur-oxygen containing compositions and a process of production
CA822117A (en) Organo-zinc compounds and processes of making same
AU444387B2 (en) Process of manufacture n-mercaptomethyl-phthalimide
CA826698A (en) Production of 3-ketobutanol-(1)
AU5661469A (en) Manufacture of bipyridlylium and related compounds
CA805167A (en) Benzene-sulphonyl-urea compounds and process of preparing same
CA808696A (en) Production of unsymmetrical dialkylhydrazines
CA810152A (en) Photographic product and method of making same
CA801036A (en) Basic-substituted diphenyl-methyl-ethers and a process of making same